IL147924A0 - Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents - Google Patents

Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents

Info

Publication number
IL147924A0
IL147924A0 IL14792400A IL14792400A IL147924A0 IL 147924 A0 IL147924 A0 IL 147924A0 IL 14792400 A IL14792400 A IL 14792400A IL 14792400 A IL14792400 A IL 14792400A IL 147924 A0 IL147924 A0 IL 147924A0
Authority
IL
Israel
Prior art keywords
arylmethyl
carbonylamino
antitumor agents
thiazole derivatives
thiazole
Prior art date
Application number
IL14792400A
Other languages
English (en)
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of IL147924A0 publication Critical patent/IL147924A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL14792400A 1999-08-12 2000-08-11 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents IL147924A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/372,832 US6114365A (en) 1999-08-12 1999-08-12 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
PCT/IB2000/001423 WO2001014353A1 (en) 1999-08-12 2000-08-11 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents

Publications (1)

Publication Number Publication Date
IL147924A0 true IL147924A0 (en) 2002-08-14

Family

ID=23469806

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14792400A IL147924A0 (en) 1999-08-12 2000-08-11 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
IL147924A IL147924A (en) 1999-08-12 2002-01-31 History of Arimethylm - Carbonyl Amino - Thiazole and Their Use in the Treatment of Cultured Diseases Cells Related to Abnormal Kinase Activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147924A IL147924A (en) 1999-08-12 2002-01-31 History of Arimethylm - Carbonyl Amino - Thiazole and Their Use in the Treatment of Cultured Diseases Cells Related to Abnormal Kinase Activity

Country Status (36)

Country Link
US (3) US6114365A (cs)
EP (1) EP1204649B1 (cs)
JP (1) JP4864260B2 (cs)
KR (2) KR100827563B1 (cs)
CN (1) CN100410245C (cs)
AP (1) AP1853A (cs)
AT (1) ATE375987T1 (cs)
AU (1) AU782882B2 (cs)
BG (1) BG65484B1 (cs)
BR (1) BR0013281A (cs)
CA (1) CA2381097C (cs)
CY (1) CY1107108T1 (cs)
CZ (1) CZ303138B6 (cs)
DE (1) DE60036803T2 (cs)
DK (1) DK1204649T3 (cs)
EA (1) EA005375B1 (cs)
EE (1) EE04939B1 (cs)
ES (1) ES2295056T3 (cs)
GE (1) GEP20053475B (cs)
HK (1) HK1054233B (cs)
HR (1) HRP20020127B1 (cs)
HU (1) HUP0202492A3 (cs)
IL (2) IL147924A0 (cs)
IS (1) IS2594B (cs)
MA (1) MA25433A1 (cs)
MX (1) MXPA02001508A (cs)
NO (1) NO323576B1 (cs)
NZ (1) NZ517236A (cs)
OA (1) OA12047A (cs)
PT (1) PT1204649E (cs)
RS (1) RS50300B (cs)
SI (1) SI1204649T1 (cs)
SK (1) SK287373B6 (cs)
UA (1) UA72538C2 (cs)
WO (1) WO2001014353A1 (cs)
ZA (1) ZA200201117B (cs)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6407103B2 (en) 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
HUP0202708A3 (en) 1999-04-15 2004-12-28 Bristol Myers Squibb Co Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
US6291504B1 (en) 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
AU2002215053A1 (en) * 2000-11-27 2002-06-24 Pharmacia Italia S.P.A. Phenylacetamido- pyrazole derivatives and their use as antitumor agents
WO2002044174A2 (en) * 2000-12-01 2002-06-06 Bristol-Myers Squibb Pharma Company 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors
US6849631B2 (en) 2000-12-08 2005-02-01 Bristol Myers Squibb Pharma Company Semicarbazides and their uses
EP1347971B1 (en) * 2000-12-21 2006-03-01 Bristol-Myers Squibb Company Thiazolyl inhibitors of tec family tyrosine kinases
EP1256578B1 (en) * 2001-05-11 2006-01-11 Pfizer Products Inc. Thiazole derivatives and their use as cdk inhibitors
EP1724270A3 (en) 2001-07-19 2007-01-03 Pfizer Italia S.r.l. Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
PL367938A1 (en) * 2001-07-19 2005-03-07 Pharmacia Italia S.P.A. Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
US7087768B2 (en) * 2001-09-27 2006-08-08 Equispharm Co., Ltd. Fumagillol derivatives and preparing method thereof
EP2305648A1 (en) * 2001-12-21 2011-04-06 Novo Nordisk A/S Amide derivatives useful as glucokinase activators
CA2488642C (en) * 2002-06-27 2011-09-06 Dharma Rao Polisetti Aryl carbonyl derivatives as glucokinase activators
FR2850380B1 (fr) * 2003-01-23 2006-07-07 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
BRPI0407456A (pt) * 2003-02-12 2006-01-31 Pfizer Derivados antiproliferativos de 2-(sulfo-fenil)-aminotiazole e composições farmacêuticas, e métodos para o seu uso
JP2006518368A (ja) * 2003-02-21 2006-08-10 ファイザー・インク プロテインキナーゼ阻害剤としてのｎ−ヘテロシクリル置換アミノチアゾール誘導体
WO2004087138A1 (en) * 2003-03-31 2004-10-14 Sucampo Ag Method for treating vascular hyperpermeable disease
FR2857664B1 (fr) * 2003-07-15 2007-12-14 Oreal Nouveaux derives thiazoles et utilisation de ces derives pour la teinture des fibres keratiniques
WO2005014591A1 (en) * 2003-07-15 2005-02-17 L'oreal 2-acylamino or 2-sulfonylamino-1, 3-thiazoles as couplers for the oxidation dyeing of keratin fibres
US7351727B2 (en) * 2003-09-02 2008-04-01 Bristol-Myers Squibb Company Inhibitors of 15-lipoxygenase
US20050074424A1 (en) * 2003-10-03 2005-04-07 Lev Salnikov Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method
AU2003297904A1 (en) * 2003-12-12 2005-07-14 University Of Maryland, Baltimore Immunomodulatory compounds that target and inhibit the py+3 binding site of tyrosene kinase p56 lck sh2 domain
SI1723128T1 (sl) 2004-01-06 2013-04-30 Transtech Pharma, Inc. Heteroaril uree in njihova uporaba kot aktivatorji glukokinaze
AU2005209442B2 (en) * 2004-01-16 2011-03-31 Sanofi-Aventis Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
WO2006002119A2 (en) 2004-06-18 2006-01-05 Gpc Biotech, Inc. Kinase inhibitors for treating cancers
EP1621539A1 (en) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621536A1 (en) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1781287A4 (en) * 2004-08-13 2008-02-27 Genentech Inc THIAZOLE-BASED COMPOUNDS HAVING ENZYMATIC INHIBITORY ACTIVITY USING ADENOSINE TRIPHOSPHATE (ATP)
EP1674457B1 (en) 2004-12-23 2009-06-03 GPC Biotech AG Derivatives of squaric acid with anti-proliferative activity
MX2007015216A (es) * 2005-06-03 2008-02-22 Xenon Pharmaceuticals Inc Derivados de aminotiazol y sus usos como agentes terapeuticos.
JP2009500378A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
EP2377856A1 (en) 2005-07-14 2011-10-19 Novo Nordisk A/S Urea glucokinase activators
EP1914234A1 (en) * 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
EP2118083A1 (en) * 2007-01-09 2009-11-18 Novo Nordisk A/S Urea glucokinase activators
CA2675111C (en) 2007-01-11 2016-04-05 Novo Nordisk A\S Urea glucokinase activators
BRPI0807626B1 (pt) * 2007-02-13 2022-03-03 Ab Science Processo para a síntese de compostos de 2-aminotiazol como inibidores de quinase
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
TWI437986B (zh) * 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
WO2009151683A2 (en) 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2112152A1 (en) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones as Plk Inhibitors
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
BRPI0920927A2 (pt) 2008-11-13 2019-09-24 Link Medicine Corp derivados de azaquinolinona e usos dos mesmos
UA103918C2 (en) * 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
TWI504598B (zh) * 2009-03-20 2015-10-21 Onyx Therapeutics Inc 結晶性三肽環氧酮蛋白酶抑制劑
EP2440556A1 (en) * 2009-06-10 2012-04-18 Vertex Pharmaceuticals Incorporated Inhibitors of phosphatidylinositol 3-kinase
DE102009043260A1 (de) * 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
EP2325185A1 (en) 2009-10-28 2011-05-25 GPC Biotech AG Plk inhibitor
HU0900798D0 (en) 2009-12-21 2010-03-01 Vichem Chemie Kutato Kft 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
WO2012092471A2 (en) * 2010-12-29 2012-07-05 Development Center For Biotechnology Novel tubulin inhibitors and methods of using the same
RU2011122942A (ru) 2011-06-08 2012-12-20 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Новые ингибиторы киназ
CN103387551B (zh) * 2012-05-11 2015-05-20 中国人民解放军军事医学科学院毒物药物研究所 噻唑类化合物及其用途
HRP20180285T1 (hr) 2012-08-23 2018-04-20 Virostatics Srl Novi 4,6-disupstituirani derivati aminopirimidina
HRP20201954T1 (hr) 2016-04-11 2021-02-05 Genfit Metode liječenja kolestatskih i fibrotičnih bolesti
AU2018380132B2 (en) 2017-12-06 2023-11-09 Lin Bioscience, Inc. Tubulin inhibitors
EP3746422A4 (en) * 2018-02-01 2021-06-09 The University Of Sydney ANTI-CANCER COMPOUNDS
EP4487909A3 (en) 2018-06-12 2025-03-19 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
EP3941900A1 (en) 2019-03-22 2022-01-26 Deutsches Krebsforschungszentrum Novel inhibitors of histone deacetylase 10
EP3712127A1 (en) 2019-03-22 2020-09-23 Deutsches Krebsforschungszentrum Novel inhibitors of histone deacetylase 10
CN114728909A (zh) * 2019-09-25 2022-07-08 韩国原子力医学院 含有新型三氟甲基苯基吡唑衍生物作为活性成分用于预防或治疗癌症的组合物
WO2021162054A1 (ja) * 2020-02-10 2021-08-19 学校法人順天堂 ２型リアノジン受容体活性抑制剤
WO2021167840A1 (en) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof
CN115322208B (zh) * 2021-05-10 2023-04-11 中国药科大学 2-氨基噻唑类衍生物及其制备方法和医药用途
AU2023239988A1 (en) * 2022-03-22 2024-10-10 Autotelic Bio Inc. Thiazole derivative compound and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125062C (cs) * 1960-04-20
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
JPH1095777A (ja) * 1996-07-31 1998-04-14 Otsuka Pharmaceut Co Ltd チアゾール誘導体
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
ES2256968T3 (es) 1997-10-27 2006-07-16 Agouron Pharmaceuticals, Inc. Derivados de 4-aminotiazol, su preparacion y su uso como inhibidores de quinasas dependientes de ciclina.
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
ATE288904T1 (de) * 1998-06-18 2005-02-15 Bristol Myers Squibb Co Durch kohlenstoff substituierte aminothiazole als inhibitoren von zyclin-abhägigen kinasen
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
HUP0202708A3 (en) * 1999-04-15 2004-12-28 Bristol Myers Squibb Co Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6992081B2 (en) * 2000-03-23 2006-01-31 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
SE0102440D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compound
US6936629B2 (en) * 2001-12-21 2005-08-30 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
AR042941A1 (es) * 2003-01-27 2005-07-06 Fujisawa Pharmaceutical Co Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1)

Also Published As

Publication number Publication date
EA200200247A1 (ru) 2002-08-29
EP1204649B1 (en) 2007-10-17
KR20020060159A (ko) 2002-07-16
NZ517236A (en) 2004-11-26
YU9702A (sh) 2004-11-25
UA72538C2 (en) 2005-03-15
US6784198B1 (en) 2004-08-31
PT1204649E (pt) 2008-01-10
US6114365A (en) 2000-09-05
BG106481A (en) 2002-09-30
EA005375B1 (ru) 2005-02-24
AP2002002441A0 (en) 2002-03-31
CN100410245C (zh) 2008-08-13
SK1802002A3 (en) 2003-05-02
IL147924A (en) 2008-03-20
HUP0202492A2 (hu) 2002-11-28
JP2003507461A (ja) 2003-02-25
SI1204649T1 (sl) 2008-02-29
CN1425009A (zh) 2003-06-18
NO20020683D0 (no) 2002-02-11
HRP20020127B1 (en) 2010-08-31
HUP0202492A3 (en) 2004-12-28
NO20020683L (no) 2002-04-10
DE60036803D1 (de) 2007-11-29
OA12047A (en) 2006-05-02
ES2295056T3 (es) 2008-04-16
BG65484B1 (bg) 2008-09-30
EE04939B1 (et) 2007-12-17
CA2381097C (en) 2009-06-16
KR100827563B1 (ko) 2008-05-07
WO2001014353A1 (en) 2001-03-01
IS2594B (is) 2010-03-15
IS6264A (is) 2002-02-11
EP1204649A1 (en) 2002-05-15
MXPA02001508A (es) 2003-07-21
AU7440000A (en) 2001-03-19
SK287373B6 (sk) 2010-08-09
AP1853A (en) 2008-05-29
ZA200201117B (en) 2003-04-30
EE200200064A (et) 2003-04-15
JP4864260B2 (ja) 2012-02-01
AU782882B2 (en) 2005-09-08
GEP20053475B (en) 2005-03-25
NO323576B1 (no) 2007-06-11
DE60036803T2 (de) 2008-07-24
CZ2002486A3 (cs) 2002-11-13
RS50300B (sr) 2009-09-08
KR20070074003A (ko) 2007-07-10
HK1054233B (zh) 2009-05-29
CA2381097A1 (en) 2001-03-01
CZ303138B6 (cs) 2012-04-25
HK1054233A1 (zh) 2003-11-21
ATE375987T1 (de) 2007-11-15
MA25433A1 (fr) 2002-04-01
BR0013281A (pt) 2002-06-18
CY1107108T1 (el) 2012-10-24
US20050004120A1 (en) 2005-01-06
PL353588A1 (en) 2003-12-01
DK1204649T3 (da) 2007-12-03
KR100773709B1 (ko) 2007-11-09
HRP20020127A2 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
IL147924A0 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
MXPA03004644A (es) Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales.
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
EG23817A (en) 4-Phenyl-pyridine derivatives
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
PL354240A1 (en) Amino-triazolopyridine derivatives
GC0000183A (en) 3-Phenyl-pyridine derivatives
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
NZ514062A (en) Diaryl derivatives and their use as medicaments
GC0000338A (en) 5-Phenyl-pyrimidine derivatives
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
IL145739A0 (en) 13-methyl-erythromycin derivatives
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
GB9925880D0 (en) B-Carboline derivatives
IL147636A0 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
IL145949A0 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
PL355845A1 (en) Substituted isoquinoline derivatives and their use as inticonvulsants
IL135452A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
EP1240156A4 (en) 3-METHYL CHROME OR THIOCHROME DERIVATIVES

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed